Many thanks to the Cancer Impact Fund for recognizing the clinical significance of Amplified Sciences' pancreatic cancer diagnostic PanCystPro, which enables accurate, early detection of pancreatic cancer. You can learn more about PanCystPro and share feedback here: https://lnkd.in/g-kN-_Ec
Honored to share the news that Amplified Sciences, Inc. has been selected as a finalist in the CANCER FUND Impact Investments™ last investment cycle of the year. We are one of five companies selected 🎊 — out of 238 evaluated — to advance to the final steps of the Pancreatic Cancer Investment Cycle for the next investment they plan to make through Cancer Fund 1. We celebrate this as a testament to the hard work our team has done to deliver the innovative test #PanCystPro serving an important clinical need. Clearly, the CANCER FUND Impact Investments™ community recognizes the importance of early detection in high risk patients for pancreatic cancer. Want to learn more interested, check out this link: https://lnkd.in/g-kN-_Ec and be sure to show interest soon – this stage of the cycle closes on December 11th. Anthony Bajoras Jeff Rea Jacob Rayyan #PancreaticCancer #DiagnosticsIsPower #EarlyDetection #oncologystartups 👉 https://lnkd.in/g-kN-_Ec
